15 Tell NICE about a topic

NICE process and methods

There will be a common proforma for topic suggestions, with a single letterbox or email: topics@nice.org.uk.

Additionally, information about topics can be provided directly to:

NICE's interventional procedures notification page (for interventional procedures).
UK PharmaScan (for medicines).
NHS Innovation Service (for devices, diagnostics and digital health technologies).
NICE Advice can help inform market access strategies for all types of technology. They can provide help to understand the healthcare landscape, identify the most appropriate route to NHS access, and explore the value of the technology with system stakeholders.
NICE Advice can also help companies develop evidence that demonstrates the clinical and cost effectiveness of all types of technology. They provide feedback on evidence generation plans, and help companies understand health technology assessment and the perspective of decision makers. NICE Advice also provides a comprehensive peer review service for economic models that helps companies optimise the model's structure, computation, coding, usability and transparency.
For medicines that have been selected for NICE guidance, the NICE commercial and managed access teams can arrange discussions between NICE, NHS England (NHSE) and companies. This supports timely discussions to address issues of value, affordability and transactability, as appropriate, to give patients the fastest possible access to clinically and cost-effective treatments. Companies can email NICE's Commercial Liaison Team (which includes NICE's Patient Access Schemes Liaison Unit [PASLU]). The Commercial Liaison Team will then arrange discussions with the Managed Access Team at NICE or the NHSE Commercial Medicines Directorate, or both, as necessary.